Skip to content

Dietary Requirement for Vitamin D in Adolescents Aged 14-18 Years

A Dose-response, Double-blind Randomised Placebo-controlled Trial to Estimate the Dietary Requirement for Vitamin D in Caucasian Male and Female Adolescents Aged 14-18 Years (The ODIN Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02150122
Enrollment
120
Registered
2014-05-29
Start date
2014-10-31
Completion date
2015-03-31
Last updated
2016-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Serum 25-hydroxyvitamin D Concentrations (25OHD)

Keywords

Vitamin D, Serum 25-hydroxyvitamin D (25OHD), Adolescents

Brief summary

It is known that low vitamin D status is a very common problem in the UK. It is also known that a lack of vitamin D availability has potentially serious health implications, especially with respect to bone and muscle function. Much research has recently taken place to establish the vitamin D requirements of key population groups (i.e. pregnant women, the elderly, ethnic minorities). However few data are available describing the vitamin D requirements for male and female adolescents. The period of adolescence is a key stage of growth and development - poor nutrition during this time can have detrimental health consequences for a lifetime. No intervention studies have comprehensively investigated the vitamin D requirements of adolescents. The proposed ODIN Study will enable a better understanding of how adolescents respond to vitamin D supplementation and the most effective daily amount that will raise and maintain vitamin D status in adolescents during the winter-time. In addition, investigations into the mechanisms of action with respect to any differences observed across the doses of vitamin D and between the genders of the participants will also provide key information. Mechanisms of action will focus on genetic differences as well as differences in vitamin D metabolising enzymes. The results obtained from this significant study will not only inform the European Food Standards Agency (EFSA) with respect to their imminent deliberations regarding vitamin D recommendations. The ODIN Study will also inform the UK Department of Health's Scientific Advisory Committee on Nutrition (SACN), the wider scientific community and be a critical resource for key stakeholders (i.e. food industry, government health agencies) to collaborate in determining future public health strategies, thus potentially positively impacting on the health of the population for years to come. The investigators propose that the daily supplementation of 10µg/day (400 IU) and 20µg/day (800 IU) of vitamin D3 for five months will meet the vitamin D requirements of males and females aged 14-18 year and will be sufficient to maintain winter-time 25OHD levels above a range of thresholds between 30 and 50nmol/l.

Interventions

DIETARY_SUPPLEMENTVitamin D3

Sponsors

University of Surrey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
14 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female * Aged between 14 and 18 years * Caucasian ethnicity * In good health * Written informed consent from the adolescent (and parent if required)

Exclusion criteria

* Currently receiving treatment for medical conditions likely to affect vitamin D metabolism * Hypercalcaemia (\>2.5mmol/l) * Regular use of sun-beds * Having a sun holiday one month prior to commencing the trial or plans for a sun holiday within the study period. * Use of vitamin supplements containing vitamin D - if the prospective participant agrees to stop vitamin D supplementation to join the study, a wash-out period of 8 weeks prior to commencing the trial would be acceptable. * Excessive consumption of alcohol (\>14 units per week for females, \>21 units per week for males) * Smoking \>10 cigarettes per day * Those following a weight-reducing diet or under dietary restriction (except vegetarianism) * Known intolerance/allergy to the constituent ingredients of the daily supplement * Clinically significant haematological abnormalities other than mild anaemia (Hb\<12.0g/dl) * Active malignancy * Pregnant or planning a pregnancy during the study period. * Breast-feeding mothers

Design outcomes

Primary

MeasureTime frameDescription
Serum 25-hydroxyvitamin D concentrationsBaseline and after 5 months of supplementationTo investigate the vitamin D intakes needed to maintain serum 25-hydroxyvitamin D (25OHD) concentrations above the deficiency and insufficiency cut off thresholds (30nmol/l and 50nmol/l respectively) in male and female adolescents during the winter time.

Other

MeasureTime frameDescription
Identification of genetic polymorphisms for vitamin DBaseline and after 5 months of supplementationTo investigate the mechanisms (genetic/enzymatic) underlying the differences observed in the preceding objective via genotyping the participants for polymorphisms related to vitamin D metabolism. Secondary analyses will include evaluation of variations in the response to supplementation by single SNP variations and by the genetic vitamin D risk score. To determine, through transcriptomic (global mRNA) analysis of leukocyte samples, genome-wide differences in gene expression, in the adolescents in response to the vitamin D3 supplementation.
Family links in vitamin D levels and bone healthBaselineTo determine the bone mineral density and vitamin D levels (in addition to the assessment of related blood markers and lifestyle factors) of the mothers of the adolescent participants, in order to establish possible familial links in the factors that affect vitamin D status and bone health.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026